section name header

Interacting Drugs

OBJECT DRUGS

Anticoagulants, Oral:

PRECIPITANT DRUGS

HMG CoA Reductase Inhibitors:


Comment:

Fluvastatin, and to a lesser degree, lovastatin and simvastatin, inhibit CYP2C9 and may increase the hypoprothrombinemic response to warfarin in some patients Rosuvastatin has been noted to increase the INR in patients taking warfarin.


Class 3: Assess Risk & Take Action if Necessary